IART has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
IART has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.
Integra Lifesciences Holdings's adjusted earnings per share data for the three months ended in Dec. 2023 was $0.250. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $1.16 for the trailing ten years ended in Dec. 2023.
During the past 12 months, Integra Lifesciences Holdings's average E10 Growth Rate was 17.20% per year. During the past 3 years, the average E10 Growth Rate was 22.60% per year. During the past 5 years, the average E10 Growth Rate was 15.20% per year. During the past 10 years, the average E10 Growth Rate was 6.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.
During the past 13 years, the highest 3-Year average E10 Growth Rate of Integra Lifesciences Holdings was 220.80% per year. The lowest was -7.20% per year. And the median was 11.15% per year.
As of today (2024-04-29), Integra Lifesciences Holdings's current stock price is $28.86. Integra Lifesciences Holdings's E10 for the quarter that ended in Dec. 2023 was $1.16. Integra Lifesciences Holdings's Shiller PE Ratio of today is 24.88.
During the past 13 years, the highest Shiller PE Ratio of Integra Lifesciences Holdings was 120.71. The lowest was 24.43. And the median was 73.43.
The historical data trend for Integra Lifesciences Holdings's E10 can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integra Lifesciences Holdings Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
E10 | Get a 7-Day Free Trial | 0.99 | 1.05 | 1.06 | 1.17 | 1.16 |
For the Medical Devices subindustry, Integra Lifesciences Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Integra Lifesciences Holdings's Shiller PE Ratio distribution charts can be found below:
* The bar in red indicates where Integra Lifesciences Holdings's Shiller PE Ratio falls into.
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.
What is E10? How do we calculate E10?
E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.
If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.
We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
For example, Integra Lifesciences Holdings's adjusted earnings per share data for the three months ended in Dec. 2023 was:
Adj_EPS | = | Earnings per Share (Diluted) | / | CPI of Dec. 2023 (Change) | * | Current CPI (Dec. 2023) |
= | 0.25 | / | 129.4194 | * | 129.4194 | |
= | 0.250 |
Current CPI (Dec. 2023) = 129.4194.
Integra Lifesciences Holdings Quarterly Data
per share eps | CPI | Adj_EPS | |
201403 | 0.035 | 99.695 | 0.045 |
201406 | 0.075 | 100.560 | 0.097 |
201409 | 0.145 | 100.428 | 0.187 |
201412 | 0.260 | 99.070 | 0.340 |
201503 | 0.125 | 99.621 | 0.162 |
201506 | 0.070 | 100.684 | 0.090 |
201509 | -0.450 | 100.392 | -0.580 |
201512 | 0.195 | 99.792 | 0.253 |
201603 | 0.180 | 100.470 | 0.232 |
201606 | 0.160 | 101.688 | 0.204 |
201609 | 0.250 | 101.861 | 0.318 |
201612 | 0.350 | 101.863 | 0.445 |
201703 | 0.080 | 102.862 | 0.101 |
201706 | 0.140 | 103.349 | 0.175 |
201709 | 0.040 | 104.136 | 0.050 |
201712 | 0.560 | 104.011 | 0.697 |
201803 | 0.140 | 105.290 | 0.172 |
201806 | 0.140 | 106.317 | 0.170 |
201809 | 0.150 | 106.507 | 0.182 |
201812 | 0.290 | 105.998 | 0.354 |
201903 | 0.380 | 107.251 | 0.459 |
201906 | 0.340 | 108.070 | 0.407 |
201909 | -0.320 | 108.329 | -0.382 |
201912 | 0.178 | 108.420 | 0.212 |
202003 | 0.110 | 108.902 | 0.131 |
202006 | -0.004 | 108.767 | -0.005 |
202009 | 0.380 | 109.815 | 0.448 |
202012 | 1.090 | 109.897 | 1.284 |
202103 | 0.530 | 111.754 | 0.614 |
202106 | 0.410 | 114.631 | 0.463 |
202109 | 0.510 | 115.734 | 0.570 |
202112 | 0.530 | 117.630 | 0.583 |
202203 | 0.390 | 121.301 | 0.416 |
202206 | 0.540 | 125.017 | 0.559 |
202209 | 0.600 | 125.227 | 0.620 |
202212 | 0.630 | 125.222 | 0.651 |
202303 | 0.290 | 127.348 | 0.295 |
202306 | 0.050 | 128.729 | 0.050 |
202309 | 0.240 | 129.860 | 0.239 |
202312 | 0.250 | 129.419 | 0.250 |
Add all the adjusted EPS together and divide 10 will get our e10.
If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.
For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.
The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
Integra Lifesciences Holdings's Shiller P/E Ratio of today is calculated as
Shiller PE Ratio | = | Share Price | / | E10 |
= | 28.86 | / | 1.16 | |
= | 24.88 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
During the past 13 years, the highest Shiller P/E Ratio of Integra Lifesciences Holdings was 120.71. The lowest was 24.43. And the median was 73.43.
Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.
Thank you for viewing the detailed overview of Integra Lifesciences Holdings's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.
Chantal Veillon-berteloot | officer: EVP & CHRO | 1100 CAMPUS ROAD, PRINCETON NJ 08540 |
Jeffrey Mosebrook | officer: SVP, Fin & PAO | 311 ENTERPRISE DRIVE, PLAINSBORO NJ 08536 |
Lea Daniels Knight | officer: EVP & CFO | 1100 CAMPUS ROAD, PRINCETON NJ 08540 |
Eric Schwartz | officer: Corp VP, Gen Counsel & Sec | C/O ERESEARCHTECHNOLOGY, INC., 1818 MARKET STREET, SUITE 1000, PHILADELPHIA PA 19103 |
Witte Jan De | director, officer: President & CEO | C/O RESMED INC., 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA 92123 |
Michael J. Mcbreen | officer: Executive VP & President, CSS | 1100 CAMPUS ROAD, PRINCETON NJ 08540 |
Harvinder Singh | officer: Exec VP & PRES, International | 1100 CAMPUS ROAD, PRINCETON NJ 08540 |
Lisa Evoli | officer: Chief Human Resources Officer | 311 ENTERPRISE DRIVE, PLAINSBORO NJ 08536 |
Raymond G. Murphy | director | 14604 CARROLTON ROAD, ROCKVILLE MD 20853 |
Renee Wonlai Lo | director | 1100 CAMPUS ROAD, PRINCETON NJ 08540 |
Glenn Coleman | officer: CVP, CHIEF FINANCIAL OFFICER | C/O DENTSLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Tru St Partnership, L.p. | 10 percent owner | 795 EAST LANCASTER AVE., STE. 200, VILLANOVA PA 19085 |
Peter J Arduini | officer: President & COO | 311 ENTERPRISE DRIVE, PLAINSBORO NJ 08536 |
Shaundra Clay | director | 1100 CAMPUS ROAD, PRINCETON NJ 08540 |
Stuart Essig | director, officer: President and CEO | 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536 |
From GuruFocus
By PRNewswire • 11-14-2023
By Marketwired • 10-23-2023
By PRNewswire • 10-21-2023
By PRNewswire • 10-24-2023
By Marketwired • 11-04-2023
By Marketwired • 10-20-2023
By PRNewswire • 11-14-2023
By PRNewswire • 10-24-2023
By PRNewswire • 11-14-2023
By GuruFocus Research • 10-25-2023